Ani Pharmaceuticals Cash Flow Statement (2010-2026) | ANIP

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-14.15M	-4.43M	-24.14M	-20.13M	-14.92M	-8.60M	-4.24M	1.44M	6.25M	9.91M	1.15M	18.21M	-2.29M	-24.17M	-10.27M	15.69M	8.53M	26.62M	27.49M	29.49M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)	2.81M	0.02M	2.97M	3.24M	0.02M	0.01M	3.74M	4.34M	5.25M	5.44M	5.62M	6.93M	7.86M	7.49M	7.06M	8.87M	9.60M	9.69M	9.77M	10.19M
Deferred Taxes (Quarter)	-6.40M	-1.99M	-8.09M	-7.46M	-3.91M	-2.25M	-1.62M	0.77M	-0.91M	-3.26M	-8.35M	3.10M	-1.90M	-5.59M	-17.53M	-3.38M	-3.54M	18.80M	2.36M	2.52M
Cash from Discontinued Operations (Quarter)
Gains from Sales and Divestitures (Quarter)	0.11M	0.13M	0.12M	0.16M	0.21M	0.23M	0.24M	0.23M
Gains from Investment Securities (Quarter)	0.78M	0.06M		0.77M	-1.09M	2.48M		0.52M				5.35M			-5.35M	0.28M	-0.28M	-0.29M	6.94M	-6.07M
Asset Writedowns and Impairment (Quarter)			2.37M			-0.00M									7.60M
Non-cash Items (Quarter)			6.79M				3.87M
Cash from Operations (Quarter)	0.24M	-5.40M	-12.19M	-18.94M	-11.48M	3.62M	-4.40M	21.42M	20.63M	32.17M	44.74M	18.27M	17.41M	12.47M	15.86M	34.99M	75.81M	44.05M	30.37M	58.38M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)									0.06M	0.83M	0.38M	0.37M	0.38M	2.47M	-1.70M	0.45M	0.39M	0.36M	0.56M	0.45M
Amortization of Deferred Charges (Quarter)	0.57M	0.58M	-0.80M	0.98M	0.59M	0.59M	1.00M	0.59M	0.59M	0.59M	0.95M	0.10M	0.59M	0.29M	0.32M	0.32M	0.83M	0.84M	0.35M	0.36M
Depreciation & Amortization (CF) (Quarter)	11.32M	11.35M	13.68M	14.56M	13.76M	14.17M	12.89M	14.70M	14.69M	15.21M	15.19M	14.69M	14.70M	15.75M	22.60M	22.89M	23.28M	22.63M	22.61M	20.92M
Change in Working Capital
Change in Receivables (Quarter)	0.77M	14.07M	-5.37M	3.10M	18.79M	-9.98M	25.00M	9.28M	-1.79M	5.92M	-16.76M	10.34M	-6.33M	-8.44M	25.51M	-1.78M	5.49M	26.96M	27.86M	-25.53M
Change in Inventory (Quarter)	-1.95M	-5.95M	5.55M	1.46M	9.39M	3.31M	9.46M	-1.70M	0.67M	2.27M	4.61M	2.64M	11.61M	6.36M	0.68M	0.62M	0.91M	8.16M	-3.73M	0.44M
Change in Account Payables (Quarter)	-0.77M	-1.29M	9.77M	-1.01M	5.06M	-9.07M	10.06M	3.10M	-3.90M	5.57M	2.78M	11.53M	-1.15M	-3.08M	-6.82M	5.55M	3.08M	13.77M	-7.24M	5.36M
Change in Accured Expenses (Quarter)
Change in Taxes (Quarter)	-6.03M	-0.66M	-0.64M	1.69M	-0.03M	-1.76M	-0.05M	0.09M	-0.35M	4.69M	7.57M	3.24M	-14.27M	-3.24M	12.85M	7.44M	-10.89M	-12.55M	0.47M	14.09M
Other Working Capital Changes (Quarter)	-0.82M	-0.22M	1.29M	0.14M	-1.70M	-1.05M	3.42M	-1.51M	0.06M	2.08M	8.38M	-1.35M	-0.42M	-2.04M	1.69M	3.94M	-9.84M	6.45M	4.46M	-2.69M
Investing Activities
Capital Expenditures (Quarter)	1.41M	-1.60M	0.12M	0.25M	3.02M	2.47M	3.14M	0.73M	-0.19M	-0.29M	0.08M	1.22M	7.81M	-8.39M	15.60M	2.47M	-2.19M	12.30M	1.24M	6.07M
Sales of Property, Plant and Equipment (Quarter)			2.65M				-0.75M					13.51M
Change in Intangibles (Quarter)	21.02M	0.01M	0.01M	0.23M		7.35M	0.00M	0.00M	4.33M	2.81M	2.50M			0.63M	0.09M	17.37M	2.90M	0.06M	0.16M	5.25M
Acquisitions (Quarter)			84.49M												8.20M
Cash from Investing Activities (Quarter)	-21.95M	-0.58M	-82.21M	-2.18M	-0.60M	-9.81M	-3.14M	-2.35M	-6.83M	-4.55M	-4.78M	8.93M	-4.45M	-398.52M	-10.68M	-19.85M	-6.91M	-6.16M	-1.40M	-11.32M
Financing Activities
Other financing activities (Quarter)	0.34M		1.81M	0.00M	0.20M	0.48M									1.98M
Cash from Financing Activities (Quarter)	20.90M	-3.02M	179.44M	-2.27M	-1.44M	-0.91M	-0.51M	-4.55M	80.15M	3.75M	-11.92M	-19.73M	-1.45M	291.03M	-4.91M	-9.91M	-1.75M	6.34M	-4.64M	-21.62M
Dividend Payments
Dividends Paid - Common (Quarter)			0.19M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.41M	0.34M
Additional items
Exchange Rate Effect (Quarter)														-0.07M	-0.40M	-0.30M	0.84M	0.58M	-1.35M	0.16M
Change in Cash (Quarter)	-0.81M	-9.01M	85.05M	-23.39M	-13.53M	-7.10M	-8.05M	14.52M	93.95M	31.37M	28.04M	7.48M	11.51M	-95.09M	-0.12M	4.94M	68.00M	44.81M	22.98M	25.59M
Free Cash Flow (Quarter)	-1.17M	-3.80M	-12.31M	-19.20M	-14.50M	1.16M	-7.54M	20.70M	20.82M	32.46M	44.66M	17.05M	9.61M	20.87M	0.26M	32.52M	78.00M	31.75M	29.12M	52.30M
Net Cash Flow (Quarter)	-0.81M	-9.01M	85.05M	-23.39M	-13.53M	-7.10M	-8.05M	14.52M	93.95M	31.37M	28.04M	7.48M	11.51M	-95.02M	0.27M	5.24M	67.16M	44.24M	24.33M	25.43M

Research Tools

Ani Pharmaceuticals Cash Flow Statement (2010-2026) | ANIP

Create an account

Sign In

Reset Password